Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 10, 2010 - Issue 2
Submit an article Journal homepage
954
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Optimizing treatment of schizophrenia to minimize relapse

Ludovic Samalin Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
,
Olivier Blanc Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
&
Pierre-Michel Llorca Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
Pages 147-150 | Published online: 09 Jan 2014

References

  • Lindenmayer JP, Liu-Seifert H, Kulkarni PM et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J. Clin. Psychiatry70(7), 990–996 (2009).
  • Llorca PM. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Res.161(2), 235–247 (2008).
  • Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv.55(8), 886–891 (2004).
  • Ayuso-Gutierrez JL, del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophr. Res.28(2–3), 199–206 (1997).
  • Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr. Res.90(1–3), 229–237 (2007).
  • Weiden P, Rapkin B, Mott T et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr. Bull.20(2), 297–310 (1994).
  • Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med.13(1), 177–183 (1983).
  • Byerly MJ, Nakonezny PA, and Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr. Res.100(1–3), 60–69 (2008).
  • Weiss EM, Bilder RM, Fleischhacker WW. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia. Psychopharmacology (Berl.)162(1), 11–17 (2002).
  • Harvey PD, Green MF, McGurk SR, Meltzer HY. Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl.)169(3–4), 404–411 (2003).
  • Jones PB, Barnes TR, Davies L et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch. Gen. Psychiatry63(10), 1079–1087 (2006).
  • Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med.353(12), 1209–1223 (2005).
  • Johnsen E, Jorgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry8, 31 (2008).
  • Karow A, Czekalla J, Dittmann RW et al. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J. Clin. Psychiatry68(1), 75–80 (2007).
  • Schooler NR. Relapse and rehospitalization: comparing oral and depot antipsychotics. J. Clin. Psychiatry64(Suppl. 16), 14–17 (2003).
  • Kane JM. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. J. Clin. Psychiatry67(Suppl. 5), 9–14 (2006).
  • Weiss KA, Smith TE, Hull JW, Piper AC, Huppert JD. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophr. Bull.28(2), 341–349 (2002).
  • Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Shared decision making and long-term outcome in schizophrenia treatment. J. Clin. Psychiatry68(7), 992–997 (2007).
  • Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br. J. Psychiatry172, 413–419 (1998).
  • Leucht S, Komossa K, Rummel-Kluge C et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am. J. Psychiatry166(2), 152–163 (2009).
  • Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet373(9657), 31–41 (2009).
  • Naber D, Lambert M. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. CNS Drugs23(8), 649–659 (2009).
  • Hamann J, Langer B, Leucht S, Busch R, Kissling W. Medical decision making in antipsychotic drug choice for schizophrenia. Am. J. Psychiatry161(7), 1301–1304 (2004).
  • Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J. Clin. Psychiatry62(7), 545–551 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.